Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression

Journal of the American Academy of Dermatology

Volumn 64, Issue 5, 2011, Pages 865-872

  Panasiti, Vincenzo ^a   Naspi, Antimo ^a   Devirgiliis, Valeria ^a   Curzio, Michela ^a   Roberti, Vincenzo ^a   Curzio, Gianfranca ^a   Gobbi, Silvia ^a   Calvieri, Stefano ^a   Londei, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

disease progression; insulin like growth factor binding protein 3; insulin like growth factors; melanoma; melanoma serum biomarkers; tumor produced proteases

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MELANOMA; MIDDLE AGED; ROC CURVE; SKIN NEOPLASMS; YOUNG ADULT;

EID: 79954729162     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.03.035     Document Type: Article

References (16)

1. D.M. Lipsker, G. Hedelin, E. Heid, E.M. Grosshans, and B.J. Cribier Striking increase of thin melanomas contrasts with stable incidence of thick melanomas Arch Dermatol 135 1999 1451 1456
2. A.C. Geller, S.M. Swetter, K. Brooks, M.F. Demierre, and A.L. Yaroch Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions J Am Acad Dermatol 57 2007 555 572 (Pubitemid 47384936)
3. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, and D.G. Coit Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648 (Pubitemid 32786276)
4. W. Zumkeller IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumor growth? Mol Pathol 54 2001 285 288 (Pubitemid 32928252)
5. H.M. Khandwala, I.E. McCutcheon, A. Flyvbjerg, and K.E. Friend The effects of insulin-like growth factors on tumorigenesis and neoplastic growth Endocr Rev 21 2000 215 244 (Pubitemid 32275588)
6. J.M. Chan, M.J. Stampfer, E. Giovannucci, P.H. Gann, J. Ma, and P. Wilkinson Plasma insulin-like growth factor I and prostate cancer risk: a prospective study Science 279 1998 563 566 (Pubitemid 28067285)
7. J. Ma, M. Pollak, E. Giovannucci, J.M. Chan, Y. Tao, and C. Hennekens Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Natl Cancer Inst 91 1999 620 625 (Pubitemid 29194048)
8. H. Yu, M.R. Spitz, J. Mistry, J. Gu, W.K. Hong, and X. Wu Plasma levels of insulin-like growth factor I and lung cancer risk: a case-control analysis J Natl Cancer Inst 91 1999 151 156 (Pubitemid 29042692)
9. S.E. Hankinson, W.C. Willett, G.A. Colditz, D.J. Hunter, D.S. Michaud, and B. Deroo Circulating concentrations of insulinlike growth factor I and risk of breast cancer Lancet 351 1998 1393 1396 (Pubitemid 28209997)
10. V.M. Adhami, F. Afaq, and H. Mukhtar Insulin-like growth factor-I axis as a pathway for cancer chemoprevention Clin Cancer Res 12 2006 5611 5614 (Pubitemid 44629586)
11. G. Pommier, F. Garrouste, F. el Atiq, J. Marvaldi, and M. Remacle-Bonnet Potential role of IGFBPS in the regulation of the differentiation state of human colonic carcinoma cells Growth Regul 3 1993 80 82 (Pubitemid 23131744)
12. S.M. Firth, and R.C. Baxter The role of glycosylation in the action of IGFBP-3 Prog Growth Factor Res 6 1995 223 229
13. F. Schoonjans, A. Zalata, C.E. Depuydt, and F.H. Comhaire MedCalc: a new computer program for medical statistics Comput Methods Programs Biomed 48 1995 257 262 (Pubitemid 26020881)
14. A.J. Butt, and A.C. Williams IGFBP-3 and apoptosis-a license to kill? Apoptosis 6 2001 199 205
15. U.B. Hoffmann, J.R. Westphal, G.N.P. van Muijen, and D.J. Ruiter Matrix metalloproteinases in human melanoma J Invest Dermatol 115 2000 337 344
16. S.H. Oh, O.H. Lee, C.P. Schroeder, Y.W. Oh, S. Ke, and H.J. Cha Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition Mol Cancer Ther 5 2006 2685 2695 (Pubitemid 44848995)